cancerresearch

Making Immunotherapy Safer: The Role of CrossDome

by
Illustration of researchers working together in a laboratory setting.

BY SALMA EDDAOUI Introduction T-cell immunotherapies hold immense promise in medical research as a means to effectively target and eliminate cancer and infectious diseases. However, one critical challenge associated with these therapies is the potential for unintended harm to healthy cells. This raises significant concerns regarding their safety and effectiveness. Making immunotherapy safer: T-cell Immunotherapies … Read more

USC Researchers Identify Biomarker for Chemoimmunotherapy Treatment Response in NSCLC Patients

by
Treatment Response in NSCLC Patients

Researchers at the USC Norris Comprehensive Cancer Center have identified a biomarker called CX3CR1 that may be able to predict a patient’s response to chemotherapy and immunotherapy. Six to nine weeks after the patient begins therapy, a straightforward blood test can identify the biomarker, which is expressed on T-cells. After six and nine weeks of … Read more